Announcements

  • All
  • Announcements 2009
  • Announcements 2010
  • Announcements 2011
  • Announcements 2012
  • Announcements 2017
  • Announcements 2018
  • Announcements 2019
  • Announcements 2020
  • Announcements 2021
  • Announcements 2022
  • Announcements 2024

Presentation to the Hellenic Fund and Asset Management Association Paiania, 24 April 2024 – Lavipharm held today its Annual Analysts Briefing, in accordance with the Company’s financial calendar for 2024. The presentation took place at the Athens Exchange to the members of the Hellenic Fund...

Paiania, 16 February 2024 - “Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, announces the Financial Calendar of 2024, as follows :   Wednesday, 28 February 2024 Flash Note Financial Results of the FY.2023 Thursday, 21 March 2024 Announcement of the FY.2023 Financial Report Wednesday, 24...

Peania, 14 February 2024 - Lavipharm S.A., in accordance with Regulation (EU) 596/2014, announces the cessation of the Group’s pharmaceutical wholesale activities and logistics services to third parties (3PL), and the transfer of certain assets of its subsidiary LAS to Profarm S.A. Special attention has...

Paiania, 1 December 2023 - Lavipharm S.A. announces, in accordance with Regulation 596/2014/EU, the signing of an asset purchase agreement with Boehringer Ingelheim International GmbH for the acquisition of two analgesic pharmaceutical products, Lonarid N® and Lonalgal®, for the markets of Greece and Cyprus with...

Paiania, 8 November 2023 - Lavipharm S.A. announces key financial figures for the nine-month period of 2023 and business developments during third quarter: Lavipharm Key Financial Figures Q3 2023  ...